PTGS2 and chronic myelogenous leukemia, BCR-ABL1 positive: (2002) showed higher PTGS2 protein levels in the bone marrow of 149 chronic-phase CML patients compared to normal controls, and higher PTGS2 levels were significantly associated with shorter survival.